In this study, we investigated how thyroid hormone (3,5,5-triiodo-L-thyronine, T 3 ) inhibits binding of thyroid hormone receptor (TR) homodimers, but not TRretinoid X receptor heterodimers, to thyroid hormone response elements. Specifically we asked why a small subset of TR␤ mutations that arise in resistance to thyroid hormone syndrome inhibit both T 3 binding and formation of TR␤ homodimers on thyroid hormone response elements. We reasoned that these mutations may affect structural elements involved in the coupling of T 3 binding to inhibition of TR DNA binding activity. Analysis of TR x-ray structures revealed that each of these resistance to thyroid hormone syndrome mutations affects a cluster of charged amino acids with potential for ionic bond formation between oppositely charged partners. Two clusters (1 and 2) are adjacent to the dimer surface at the junction of helices 10 and 11. ) confirmed that the clusters are required for stable T 3 binding and for optimal TR homodimer formation on DNA but also revealed that different arrangements of charged residues are needed for these effects. We propose that the charge clusters are homodimer-specific extensions of the dimer surface and further that T 3 binding promotes specific rearrangements of these surfaces that simultaneously block homodimer formation on DNA and stabilize the bound hormone. Our data yield insight into the way that T 3 regulates TR DNA binding activity and also highlight hitherto unsuspected T 3 -dependent conformational changes in the receptor ligand binding domain.
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Thyroid hormone receptors (TR␣ and TR␤) 1 are conditional transcription factors that play important roles in development, metabolism, and homeostasis (1) (2) (3) (4) . TRs regulate gene transcription in the presence of 3,5,3Јtriiodo-L-thyronine (T 3 ) and in the absence of ligand (5) . Current efforts to modulate TR activities have focused on development of selective agonists that mimic the beneficial effects of T 3 upon circulating cholesterol and body weight without producing unwanted effects of the hormone on heart rate (6) . However, there is also a need for TR antagonists, which could represent improved and faster acting treatments for hyperthyroidism and cardiac arrhythmias (6, 7) . Furthermore observations from TR␣/TR␤ knock-out mice suggest many clinical manifestations of hypothyroidism are due to actions of unliganded TRs (8, 9) . Thus, drugs that specifically reverse actions of unliganded TRs could be useful for treating hypothyroidism and would avoid risk of thyroid hormone excess (7) . Improved understanding of unliganded TR structure and ways that unliganded TRs rearrange in response to T 3 will facilitate development of all of these drugs.
Presently the organization of unliganded TR is only partly understood (10, 11) . X-ray structures of liganded TR C-terminal ligand binding domains (LBDs) reveal a canonical ␣-helical structure with T 3 buried in the core of the protein (12) (13) (14) (15) (16) , but there are no equivalent structures of unliganded TRs. It has proven possible, however, to use a combination of x-ray structural information and targeted mutagenesis to learn about the organization of unliganded TRs. For example, T 3 blocks transactivation and transrepression activities of unliganded TRs by promoting release of corepressors such as N-CoR and SMRT (silencing mediator of retinoid and thyroid receptors) (5) and induces a T 3 -dependent activation function (AF-2) that binds coactivators such as the p160s (17) . Functional analysis of TR mutants reveals that AF-2 is comprised of surface-exposed residues from helices (H) 3, 5, and 12 and that the corepressor binding surface overlaps AF-2 but extends below the position of H12 in the liganded state (18 -21) . Thus, it is possible to infer that H12 is displaced in the unliganded state and that T 3 binding leads to repositioning of H12 over the lower part of the corepressor binding surface, simultaneously promoting corepressor release and completing the coactivator binding site (5) .
T 3 also regulates TR DNA binding activity (1) . TRs utilize their DNA binding domain to recognize specific thyroid hormone response elements (TREs) comprised of AGGTCA repeats and bind these elements either as heterodimers with the closely related retinoid X receptor (RXR) or as homodimers and monomers. T 3 does not affect RXR-TR interactions with TREs but does promote release of TR homodimers from some TREs (inverted palindromes (F2/IP-6) and direct repeats (DR-4)) but not from TREs at which TRs bind as monomers or paired monomers (palindromes, TREpal) (22) . TR homodimers bind N-CoR more strongly than RXR-TR heterodimers (23, 24) , and the extent of TR homodimer binding to different TREs in vitro correlates with the extent of repression from these elements in vivo (25, 26) . Thus, it is thought that T 3 -dependent inhibition of homodimer formation relieves transcriptional repression by unliganded TRs. Nevertheless the mechanisms involved in coupling of T 3 binding to inhibition of DNA binding are not clear; TRs utilize the same surface at the junction of H10 and H11 in homodimer and heterodimer formation on DNA (27) . The structural elements that render homodimers sensitive to T 3 are not known.
In this study, we utilized targeted mutagenesis to explore elements of the TR that are specifically required for homodimer formation on TREs and tested the hypothesis that the same elements are involved in coupling T 3 binding to inhibition of DNA binding. Whereas most TR␤ mutations that arise in resistance to thyroid hormone syndrome (RTH) reduce the affinity of TR␤ for T 3 (3, 28, 29) , a small subset also inhibits binding of TR␤ homodimers, but not heterodimers, to TREs (30, 31) . Here we report that these RTH mutations affect clusters of charged amino acids in the LBD with potential for electrostatic stabilization of TR conformation but that distinct arrangements of charged residues are needed for stable T 3 binding and DNA binding by unliganded TRs. We propose that the charge clusters rearrange upon T 3 binding to block homodimer formation and create new ionic bonds that stabilize bound hormone.
MATERIALS AND METHODS
TR Mutants-The pCMX vector was used for expression of the fulllength human TR␤ (17) . Mutations within TR-encoding sequences were created using the QuikChange XL site-directed mutagenesis kit (Stratagene). Mutation of target sequences was verified by automated DNA sequence (Elim Biopharmaceuticals, Inc., Hayward, CA).
Transfections-HeLa cells were maintained in Dulbecco's modified Eagle's H-21 4.5 g/liter glucose medium containing 10% fetal bovine serum, 2 mM glutamine, 50 units/ml penicillin, and 50 mg/ml streptomycin. For transfection, cells were collected and resuspended in Dulbecco's phosphate-buffered saline (0.5 ml/4.5 ϫ 10 7 cells) containing 0.1% dextrose and typically 4 g of reporter, 1 g of TR expression vector or empty vector control, and 2 g of pCMV-␤-galactosidase (17) . Cells were electroporated at 240 V and 960 microfarads, transferred to fresh media, and plated into 12-well plates. After incubation for 24 h at 37°C with T 3 or vehicle, cells were collected, and pellets were lysed by addition of 150 l of 100 mM Tris-HCl, pH 7.8, containing 0.1% Triton X-100. The reporters contained two copies of each TRE (DR-4, F2, and TREpal) upstream of the herpes simplex virus thymidine kinase promoter TATA box linked to luciferase coding sequence. Luciferase and ␤-galactosidase activities were measured by using a luciferase assay system (Promega) and Galacto-Light Plus ␤-galactosidase reporter gene assay system (Applied Biosystems).
Glutathione S-Transferase Pull-down Assays-Full-length human TR␤ was expressed in a coupled transcription translation system (TNT, Promega). N-CoR (amino acids 1944 -2453) and GRIP1 (amino acids 563-1121) were expressed in Escherichia coli strain BL21 as a fusion protein with glutathione S-transferase according to the manufacturer's protocol (Amersham Biosciences). Bindings were performed by mixing glutathione-linked Sepharose beads containing 4 g of glutathione Stransferase fusion proteins (Coomassie Plus protein assay reagent, Pierce) with 1-2 l of ) are shown in blue (positively charged) and red (negatively charged). B and C, closer view interactions between the residues that comprise charge Clusters 1 (B) and 2 (C). Positively charged residues are shown in blue, and negatively charged residues are shown in red. Asterisk represents residues mutated in RTH. D, alignment of Cluster 1 residues in TR and other NRs. E, alignment of Cluster 2 residues in TR and other NRs. hTR, human TR; hRAR, human retinoic acid receptor; hLXR, human liver X receptor; hER, human estrogen receptor; hPXR, human pregnane X receptor; hVDR, human vitamin D receptor; hCAR, human constitutive androstane receptor.
were resuspended in SDS-PAGE loading buffer, and proteins were separated using 10% SDS-polyacrylamide gel electrophoresis and visualized by autoradiography.
T 3 Binding Assay-TRs were expressed using the TNT T7 quick coupled transcription translation system (Promega). The affinities of T 3 binding were determined using a saturation binding assay. Briefly 15 fmol of each in vitro translated protein were incubated overnight at 4°C with varying concentrations of [
125 I]T 3 (PerkinElmer Life Sciences) in 100 l of E400 buffer (400 mM NaCl, 20 mM KPO 4 , pH 8, 0.5 mM EDTA, 1.0 mM MgCl 2 , 10% glycerol), 1 mM monothioglycerol, and 50 g of calf thymus histones (Calbiochem). The bound [ 125 I]T 3 was isolated by gravity flow through a 2-ml Sephadex G-25 (Amersham Biosciences) column and quantified using a ␥-counter (COBRA, Packard Instruments). Off rate (k off ) was determined by adding a 1000-fold molar excess of unlabeled T 3 to a mixture containing TR and 1 nM [
125 I]T 3 incubated previously overnight at 4°C; aliquots were taken at the indicated time points to determine how rapidly the labeled ligand dissociates from TR. These aliquots were applied to Sephadex G-25 columns, and TR-bound [ 125 I]T 3 was quantified using a ␥-counter. As each T 3 -TR complex dissociates at a random time, the amount of specific binding follows an exponential dissociation equation: Y ϭ Span⅐e Ϫk⅐x ϩ Plateau where x is time (min), Y is total binding (cpm), Span is the difference between binding at time 0 and plateau (cpm), and k is the dissociation rate constant (k off , expressed in min Ϫ1 ). Binding curves were fit by nonlinear regression, and dissociation constant (K d ) and k off values were calculated using the one-site saturation binding, one-phase exponential decay, and onephase exponential association models, respectively, contained in the Prism version 3.03 program (GraphPad Software, Inc., San Diego, CA).
Gel Shifts-Binding of TR to DNA was assayed by mixing 20 fmol of TRs produced in a reticulocyte lysate system, TNT T7 (Promega), with 300,000 cpm [␥-
32 P]ATP-radiolabeled DR-4 and F2 oligonucleotides and 1 g of poly(dI-dC) (Amersham Biosciences) in a 20-l reaction (32) . In cases in which TR ligand binding activity was severely affected by Cluster 1 mutations, the overall amount of translated TRs in the extracts was also verified independently by Western blot. The binding buffer contained 25 mM HEPES, 50 mM KCl, 1 mM dithiothreitol, 10 M ZnSO 4 , 0.1% Nonidet P-40, 5% glycerol. After 30 min at room temperature, the mixture was loaded onto a 5% nondenaturing polyacrylamide gel that was previously run for 30 min at 200 V. To visualize the TR-DNA complexes, the gel was run at 4°C for 120 -180 min at 200 V in a running buffer containing 45 mM Tris borate (pH 8.0) and 1 mM EDTA. The gel was then fixed, dried, and exposed for autoradiography.
Statistical Analysis-All data are presented as means Ϯ S.D. Oneway ANOVA with Tukey's post-test or t test was performed using GraphPad Prism version 3.03 for Windows. Data analyzed referred to at least three independent experiments. A p value of Ͻ0.05 was considered statistically significant.
RESULTS

RTH Mutations That Inhibit T 3 and DNA Binding Reside in
Charge Clusters-RTH mutations that inhibit homodimer formation on DNA affect positively charged Arg residues (R338W, R429Q, and R316H) (30, 31, (33) (34) (35) . In addition, we found that another RTH mutation that affects a positively charged Lys residue (K342I) also inhibits homodimer formation on DNA (not shown). Investigation of TR structural models revealed that each of these amino acids lies within separate clusters of closely juxtaposed charged residues ( Fig. 1A and Table I ). The TR␤ LBD contains only one similar charge cluster that is not known to be affected by RTH mutations (Cluster 4, see Table I ).
Clusters 1 and 2 are comprised of residues that are exposed or partially exposed on the surface of the LBD and are both adjacent to the classical dimer surface at the junction of H10 and H11 (Fig. 1A and Table I ). Unlike many residues that are affected by RTH mutations, none of the residues in the clusters directly contacts T 3 or comprises part of a known coregulator binding surface. (Fig. 1D) . Residues in Cluster 2 show even better conservation (Fig. 1E) . Together all of these considerations indicate that the charge clusters play an important, and unappreciated, role in TR activities. Furthermore the fact that mutations in the clusters affect T 3 binding and homodimer formation indicates that the clusters must play a role in activities associated with liganded and unliganded TRs.
Cluster 1 Is Required for Optimal T 3 Binding-We first examined effects of mutations in Cluster 1 on activities of liganded TRs. Because residues of this cluster are completely surface-exposed it appeared unlikely that these mutations would exert indirect effects on TR function by disrupting internal folding of the LBD. We introduced 1) Ala substitutions, which swap a residue with a small neutral side chain for a residue with a charged side chain and thereby eliminate the potential for electrostatic interactions, and 2) charge reversal mutations, which should disrupt ionic bonds between oppositely charged residues by juxtaposing residues with like charges. Fig. 2A) . Nevertheless several TR␤ Cluster 1 mutants displayed altered T 3 concentration dependence (Fig. 2B and A relatively mild Ala substitution mutation (TR␤K342A) had either no effect or slightly enhanced T 3 sensitivity (Table II) . Nevertheless a more severe charge reversal mutation, TR␤K342D, exhibited decreased T 3 sensitivity as did the TR␤K342I RTH mutant (not shown). Finally mutations at Asp 355 did not reduce T 3 sensitivity. TR␤D355A and TR␤D355R either exhibited T 3 sensitivity com- parable to wild type TR␤ or enhanced T 3 sensitivity at some reporters ( Fig. 2B and Table II) . None of the Cluster 1 mutations impaired binding to a coactivator (GRIP1, Fig. 3A) or to a corepressor (N-CoR, Fig. 3A ) in pull-down assays in vitro. This is consistent with the results that show no impairment in the maximal effect of the hormone in transfection assays. By contrast, the same mutations that reduced T 3 sensitivity in vivo also reduced the affinity of the TR for T 3 (Fig. 3B ) and increased T 3 dissociation rates (Fig. 3C) (Fig. 1B) .
Mutations in Cluster 1 Can Either Impair or Enhance Homodimer Binding to DNA, and Effects Do Not Correlate with T 3
Binding-Next we examined effects of mutations in Cluster 1 on TR homodimer formation on DNA. The data in Fig. 4A confirmed that the TR␤R338W RTH mutant exhibits defective homodimer formation at F2 and DR-4 elements along with normal levels of heterodimer formation (30, 31) . By contrast, an artificial mutation (TR␤L422R) in the classical dimer interface abolished both homodimer and heterodimer formation. In parallel, TRs bearing Ala substitution mutants at Arg 338 and Asp 351 (both required for optimal T 3 binding) exhibited reduced homodimer but not heterodimer formation at F2 and DR-4 elements (Fig. 4B ) just like the TR␤R338W RTH mutant. However, TR␤K342A displayed reduced homodimer formation even though it did not inhibit T 3 binding (compare Figs. 2B and 4B ). More surprisingly, the charge reversal mutants exhibited enhanced DNA binding (Fig. 4C ) even though most of these mutations inhibit T 3 binding (Fig. 2B ). The precise effect of the charge reversal mutants varied; TR␤R338D showed enhanced DNA binding in the absence of T 3 , whereas TR␤D351R and TR␤K342D showed enhanced DNA binding in the presence or absence of T 3 . TR␤D355R exhibited enhanced DNA binding in the presence of T 3 , reversing the usual effects of T 3 on TR DNA binding activity (Fig. 4C ). Again these effects were largely homodimer-specific, although TR␤K342D did exhibit somewhat enhanced heterodimer formation. Together our results confirm that Cluster 1 is required for TR homodimer but not heterodimer formation on DNA. Nevertheless the same data also revealed that different arrangements of charge are needed for optimal DNA and T 3 binding. 383 , Arg 429 , and Glu 311 ) also exhibited differential effects on activity of liganded TRs and DNA binding. Fig. 5A shows that TR␤E311A exhibited a much larger reduction in T 3 sensitivity than TRs bearing mutations at Arg 429 and Arg 383 (TR␤R429A and TR␤R383H) (Fig. 5A ). This finding is consistent with previous observations that RTH mutations in these Arg residues only affect T 3 sensitivity weakly (30) and is also consistent with the organization of Cluster 2 in TR␤ structures (Fig. 1C) ; a mutation in Glu 311 that breaks electrostatic interactions with both Arg residues exhibited a more severe defect than mutations at Arg 429 and Arg 383 , which only break one bond. By contrast, TR␤E311A (and TR␤R383H) bound to DNA as efficiently as wild type TRs in the absence of T 3 , whereas TR␤R429A exhibited decreased homodimer formation on DNA (Fig. 5B) . Thus, Cluster 2 requires different charged residues for optimal T 3 response and DNA binding just like Cluster 1. Fig. 3 . B, Arg 429 is required for optimal homodimer formation. Shown are electrophoretic mobility shift assays to determine binding of Cluster 2 mutants to an F2 oligonucleotide as in Fig. 4 Fig. 6A shows that TR␤R338D,D351R displayed markedly reduced T 3 sensitivity in transfections like the R338D and D351R single mutants. TR␤R338D,D351R also displayed decreased affinity for T 3 and increased dissociation rates of bound T 3 with normal levels of coregulator binding and TR homodimer formation on DNA (not shown).
Charge Cluster 2 Residues Differentially Affect T 3 Activation and DNA Binding-Mutations in Cluster 2 (Arg
The phenotype of the TR␤R338D,D351R double mutant was surprising; it is often possible to reverse the positions of residues in ionic pairs and regenerate wild type protein function. Nevertheless Fig. 6B shows that introduction of Ala substitutions at Lys 342 and Asp 355 restored the activity of the TR␤R338D,D351R double mutant to near wild type levels but not that of a TR␤ mutant with like charges at both positions (TR␤R338D,K342A,D355A). Thus, Arg 338 and Asp 351 can be reversed without severe loss of TR␤ function, suggesting that they can form a reversible ionic bond that stabilizes liganded TR␤. This effect can only be observed, however, when other charges are removed from the cluster. Fig. 7A shows that a TR␤ double mutant bearing Ala substitutions at residues that are required for optimal T 3 binding (TR␤R338A,D351A) displayed reduced T 3 sensitivity and T 3 binding and increased dissociation rates of bound T 3 . Furthermore a TR␤ double mutant bearing Ala substitutions at residues that are not required for optimal T 3 binding (TR␤K342A,D355A) did not affect TR␤ activity. These results confirm that Arg 338 and Asp 351 are needed for optimal hormone binding, and Lys 342 and Asp 355 are not. More surprisingly, a double mutant that eliminated both positive charges in Cluster 1 (TR␤R338A,K342A) exhibited a phenotype that was similar to wild type TR␤. Furthermore a double mutant that removed both negative charges (TR␤D351A,D355A) exhibited a phenotype that was intermediate between TR␤D351A, reduced affinity for T 3 , and TR␤D355A, similar to wild type TR␤. Thus, Ala substitution mutations at Lys 342 and Asp 355 rescue effects of similar mutations at Arg 338 and Asp 351 . The fact that some mutations in Cluster 1 rescue effects of others was underscored by the observation that elimination of all charge within Cluster 1 with a quadruple Ala substitution (TR␤4A) failed to inhibit T 3 binding or liganded TR␤ function. TR␤4A displayed enhanced T 3 sensitivity in transfections (Fig.  7B) , slightly increased affinity for T 3 (Table III) , and normal levels of coactivator and corepressor binding (not shown). Nevertheless TR␤4A exhibited strongly reduced homodimer formation on DNA (Fig. 7C ). This reduction in homodimer formation, the largest obtained with any Cluster 1 mutation in this study (not shown), was paralleled by impaired repression at a TRregulated reporter without T 3 (Fig. 7B, inset) .
Together our results show that, whereas two individual residues in the cluster (Arg 338 and Asp 351 ) are required for optimal T 3 response and T 3 binding, Cluster 1 itself is dispensable for the function of liganded TR. Nevertheless Cluster 1 is required for activities associated with unliganded TRs: homodimer formation on DNA and transcriptional repression (see "Discussion").
DISCUSSION
In this study, we examined how TR DNA binding activity is regulated by its LBD and by ligand. To begin to understand this issue, we asked why some RTH mutations (R316H, R338W, K342I, and R429Q) that reduce the affinity of TR␤ for T 3 also inhibit binding of TR homodimers, but not heterodimers, to TREs (30, 31) . We reasoned that these mutations might affect structural elements that are involved in coupling T 3 binding to inhibition of DNA binding activity. We report here that each of these RTH mutations affected amino acids that lie within clusters of charged residues with potential for electrostatic interactions between individual residues in the cluster. Two of these clusters (1 and 2) are adjacent to the TR dimer/heterodimer surface (Table I and Fig. 1 ). The importance of the clusters is underscored by their conservation both in TRs across evolution (not shown) and in other NRs (Fig. 1, D and E) and by our studies, which revealed that mutations in Clusters 1 and 2 lead, variously, to increases and decreases in T 3 binding and/or DNA binding.
The existence of functionally important clusters of charged residues on the TR LBD surface was surprising because proteins are largely stabilized by hydrophobic effects in which hydrophobic residues form the interior of the protein and charged side chains are surface-exposed, freely solvated with water (37) . Nevertheless electrostatic interactions between oppositely charged side chains have been shown to provide additional stability to proteins in several contexts, including particular conformers of allosteric proteins, protein-protein interaction surfaces, and proteins in thermophilic organisms (37) (38) (39) (40) . For TRs, two RTH mutations that disrupt ionic bonds, one in Cluster 3 (TR␤R316H) and a single surface-exposed ionic bond between Arg 243 in H3 and Glu 322 at the base of H6 (TR␤R243Q), lead to broadening of experimental electron density in the lower part of the LBD in x-ray structures (14, 15) . This confirms that electrostatic interactions between oppositely charged TR␤ residues can stabilize the liganded TR␤-LBD.
Our mutational analysis supports the notion that Clusters 1 and 2 are stabilizing elements for liganded TR. Mutations that disrupted the predicted ionic bond arrangements in Clusters 1 and 2 led to reduced T 3 sensitivity, reduced affinity for T 3 , and increased T 3 dissociation rates. These phenotypes resemble those of aforementioned TR␤ RTH mutations that destabilize the TR LBD by breaking electrostatic interactions, R316H and R243Q (14, 15 (Fig. 4) .
Other results are hard to reconcile with the simple notion that Clusters 1 and 2 act as static stabilizing elements for liganded and unliganded TRs. Cluster 1 was dispensable for optimal T 3 response and T 3 binding (Fig. 7) (Fig. 7) . Our hypothesis to explain these observations is outlined in Fig. 8 . We propose that Clusters 1 and 2 are hormone-dependent stabilizing elements for the TR LBD. We suggest that, in the unliganded state, the clusters adopt an unspecified organi- zation that is distinct from that observed in x-ray structures of liganded TR␤ LBDs but required for optimal homodimer formation on DNA. Given the placement of these residues, we favor the notion that the clusters comprise homodimer-specific extensions of the dimer surface that engage in flexible contacts with oppositely charged residues in partner LBDs or possibly influence homodimer formation via distant stabilizing effects on the dimer surface. We further suggest that T 3 binding promotes structural rearrangements in the TR LBD that reposition the charged residues, simultaneously breaking the interactions that are needed for optimal homodimer formation on DNA and creating new ionic bonds that hold the walls of the hormone binding pocket in an appropriate configuration for stable T 3 interactions. Our model suggests explanations for several apparently paradoxical results. 1) Different charge arrangements are required for T 3 binding and homodimer formation on TREs because the clusters adopt different organizations in the presence and absence of T 3 . We recognize that our model cannot yet be verified directly because apoTR dimer structures are not available. Nevertheless analysis of liganded and unliganded RXR crystal structures revealed evidence that is consistent with the basic predictions of our model. First charged residues in the region of RXR that is equivalent to H8 rearrange in response to ligand binding (Fig. 9) . RXR Glu 352 and Lys 356 form an ionic bond within the interior of the unliganded LBD. Binding of 9-cisretinoic acid twists the helix, exposing the charged side chains on the protein surface where they can pair with PPARs in RXR-PPAR heterodimers (41) (42) (43) (44) (45) . We suggest that TR␤ charge clusters (on H7, H8, and H11) must undergo similar ligand-dependent rearrangements. This model implies that functionally important conformational rearrangements that accompany T 3 binding are not restricted to H12 and that T 3 induces reorganization of the opposite face of the TR near the dimer surface.
Finally our results also lend support to the notion that TR homodimers are highly active in mediating transcriptional repression in vivo (25, 26) . We observed that a TR␤ mutant that strongly inhibited homodimer formation on TREs (TR␤4A) impaired the ability of unliganded TRs to suppress transcription in the absence of hormone (Fig. 7B) . We predict that mutations such as those described here that either specifically inhibit or stabilize particular oligomeric forms of TR will help us to further dissect the relative roles of RXR-TR heterodimers and TR homodimers in vivo.
FIG. 9. Ligand-dependent rearrangements in RXR H7 (equivalent to TR␤ H8).
A schematic shows apoRXR H7 in orange and holo-RXR in gray with ligand (9-cis-retinoic acid (RA)) in gray and red. H7 changes backbone conformation: Lys 356 and Glu 352 , paired in apoRXR, move from inside to outside on ligand binding.
FIG. 8.
Model to explain coupling of T 3 binding to inhibition of TR␤ DNA binding activity. The blue spheres represent positively charged residues in Cluster 1, whereas red spheres represent negatively charged residues. The charged residues are in an unspecified organization required for homodimer formation in the absence of hormone and rearrange to form the ionic bond organization detected in our x-ray structures in the presence of hormone.
